Eli Lilly, Sitryx announce autoimmune alliance
Eli Lilly recently announced plans to postpone most new COVID-19-unrelated study starts.
Read More
Tag: Sitryx
New UK biopharma Sitryx launches with $30m fundraising
New UK biopharmaceutical group Sitryx has launched operations with $30 million to help it develop disease-modifying therapeutics in immunometabolism.
Read More
- Liverpool and McMaster University announce £300,000 strategic research partnership
- Study finds link between malaria parasites developing antimalarial drug resistance
- Researchers develop ‘digital twin’ heart models to better monitor PAH NHS patients
- Closed Loop and Pharmanovia investigate precision medicine combination in hypertension
- US study reveals interferon combinations cause lupus symptoms and affect treatment
